SALVATORE, Teresa
 Distribuzione geografica
Continente #
EU - Europa 8.485
NA - Nord America 4.266
AS - Asia 3.409
SA - Sud America 495
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 16.705
Nazione #
RU - Federazione Russa 5.483
US - Stati Uniti d'America 4.152
SG - Singapore 1.125
CN - Cina 897
IE - Irlanda 872
HK - Hong Kong 536
IT - Italia 454
BR - Brasile 404
VN - Vietnam 389
GB - Regno Unito 374
UA - Ucraina 362
DE - Germania 292
SE - Svezia 188
FR - Francia 135
FI - Finlandia 110
KR - Corea 107
IN - India 89
TR - Turchia 81
GR - Grecia 69
CA - Canada 50
JP - Giappone 44
MX - Messico 42
BD - Bangladesh 34
AR - Argentina 31
AT - Austria 28
NL - Olanda 26
IR - Iran 22
BE - Belgio 18
ES - Italia 17
CO - Colombia 16
PL - Polonia 15
ZA - Sudafrica 14
EC - Ecuador 12
ID - Indonesia 12
VE - Venezuela 10
CZ - Repubblica Ceca 8
IQ - Iraq 8
MA - Marocco 8
PE - Perù 8
PK - Pakistan 8
UZ - Uzbekistan 8
JM - Giamaica 7
LT - Lituania 6
SA - Arabia Saudita 6
CH - Svizzera 5
EG - Egitto 5
JO - Giordania 5
NP - Nepal 5
PH - Filippine 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CR - Costa Rica 4
PY - Paraguay 4
AZ - Azerbaigian 3
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KW - Kuwait 2
LB - Libano 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
AN - Antille olandesi 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
IS - Islanda 1
KE - Kenya 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 16.705
Città #
Moscow 1.952
Dublin 860
Jacksonville 545
Hong Kong 528
Singapore 500
Chandler 479
Santa Clara 445
San Jose 434
Ashburn 201
Princeton 125
Ho Chi Minh City 124
The Dalles 111
Seoul 105
Beijing 103
Hefei 100
Dallas 96
Medford 94
New York 90
Ann Arbor 88
Hanoi 87
Roxbury 82
Nanjing 71
Bengaluru 66
Boardman 57
San Mateo 54
Bremen 51
Munich 50
Naples 49
Caserta 48
Los Angeles 48
Jinan 45
Wilmington 45
São Paulo 40
Cambridge 39
Woodbridge 38
Des Moines 30
Da Nang 27
Haiphong 25
Nanchang 23
Düsseldorf 21
Tianjin 20
Kunming 19
Milan 19
Brussels 18
Orem 18
Torre Del Greco 18
Frankfurt am Main 17
Montreal 16
Mountain View 16
Zanjan 16
Shenyang 15
Memphis 14
Rome 14
Houston 13
Taiyuan 13
Vienna 13
Amsterdam 12
Atlanta 12
Changsha 12
Helsinki 12
Salerno 12
Biên Hòa 11
Guangzhou 11
Lanzhou 11
Norwalk 11
Nuremberg 11
Warsaw 11
Boston 10
Brooklyn 10
Johannesburg 10
Napoli 10
Rio de Janeiro 10
Toronto 10
Andover 9
Avellino 9
Chennai 9
Falkenstein 9
Hải Dương 9
Mexico City 9
Stockholm 9
Taizhou 9
Aversa 8
Denver 8
Dong Ket 8
Haikou 8
Tashkent 8
Tokyo 8
Ningbo 7
Phoenix 7
Quảng Ngãi 7
Sacramento 7
Seattle 7
Shanghai 7
Turku 7
Washington 7
Zhengzhou 7
Belo Horizonte 6
Brasília 6
Campinas 6
Chicago 6
Totale 8.628
Nome #
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 226
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 221
What changed in the Italian internal medicine and geriatric wards during the lockdown 197
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 193
Lo squatting test nella valutazione della neuropatia diabetica 189
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 184
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 184
Diagnosi e trattamento precoce della vasculopatia cerebrale cronica nel paziente diabetico 178
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 170
Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity 166
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 166
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 165
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 164
Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent 164
Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin 160
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
Decreased insulin clearance as a feature of essential hypertension 159
ANORECTAL FUNCTION IN DIABETES MELLITUS 159
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP 155
ALTERATIONS OF RECTAL SENSITIVITY IN DIABETIC PATIENTS 155
A double-blind controlled study on the effect of tolrestat on diabetic autonomic neuropathy 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 153
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 152
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients 150
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 146
Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus 141
Aumentata prevalenza di Diabete tipo-2 nelle famiglie di individui affetti da Diabete tipo-1 Studio di 5 anni condotto nella Regione Campania 138
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 137
LO “SQUATTING” TEST NELLA VALUTAZIONE DELLA NEUROPATIA AUTONOMICA DIABETICA 137
Dual effect of beta-endorphin on insulin secretion in man 135
HCC and molecular targeting therapies: Back to the future 135
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 132
Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects 132
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 132
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
An unusual case of primary systemic amyloidosis 131
[Obesity and myocardial infarction] 131
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 128
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 127
Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study 127
Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? 126
Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus 126
LA RIDUZIONE DELLA CLEARANCE METABOLICA DELL’INSULINA CONTRIBUISCE ALL’IPERINSULINEMIA DEL PAZIENTE CON IPERTENSIONE ESSENZIALE 126
Effect of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 126
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment 126
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 124
Is the common presence of glucose intolerance in old age a reliable index for the subsequent occurrence of fasting hyperglycemia? 124
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist 124
Comment on: Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma 123
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 123
Valutazione della secrezione esocrina pancreatica mediante Lauril e BT-PABA test nel diabete mellito 122
The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people 121
An unforseen type 1 diabetes does make a complex diagnosis 121
Low protein alimentation normalizes renal haemodynamic response to acute protein ingestion in type 1 diabetic children 120
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 118
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 117
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 116
[Large mediastinal mass of heterotopic thyroid tissue: a case report and review of literature] 114
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 114
Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia 113
Metabolic clearance rate of insulin in offspring of patients with non-insulin-dependente diabetes (NIDDM). 112
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 111
Sensorimotor evaluation of ano-rectal complex in diabetes mellitus. 111
Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects 110
Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study 109
Metabolic modifications induced by a combined insulin-glucose intravenous infusion before and after a protein-supplemented fast in obese subjects 108
Progress in the oral treatment of type 2 diabetes: update on DPP-IV inhibitors. 107
Sensitivity to beta-endorphin as a cause of human obesity 107
VALUTAZIONE DEI NUOVI CRITERI CLASSIFICATIVI DEL DIABETE MELLITO NELL’ETA’ AVANZATA 107
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 106
Fast extramedullary pleural spread in a new diagnosis of multiple myeloma 106
Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin 105
Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia 105
Evaluation of various lung physiopathology tests in subjects with chronic bronchitis before and after administration of salbutamol 104
[Non-insulin-dependent diabetes in young subjects] 103
UPPER DIGESTIVE TRACT INVOLVEMENT IN TYPE 2 (NON INSULIN DIPENDENT) DIABETES: PH-MANOMETRIC AND ENDOSCOPIC STUDY 102
INFLUENZA DELLO SFORZO SULLA PaO2 IN SOGGETTI CON SINDROME RESTRITTIVA 102
VALUTAZIONE DELLA SECREZIONE ESOCRINA PANCREATICA MEDIANTE LAURIL E BT-PAVA TEST NEL DIABETE MELLITO 102
Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 101
ESISTE UNA NETTA SEPARAZIONE NELLA PATOGENESI DELL’IPERGLICEMIA TRA DIABETICI INSULINO-DIPENDENTI E DIABETICI NON-INSULINO DIPENDENTI? 101
Heart failure and chronic kidney disease in a registry of internal medicine wards 101
HETEROGENEITY IN THE PATHOPHYSIOLOGY OF INSULIN SECRETION IN NON-INSULIN DEPENDENT DIABETES 100
CORRELATION BETWEEN NAILFOLD VIDEOCAPILLAROSCOPY PATTERNS, LEFT VENTRICLE DYSFUNCTION AND PULMONARY DISEASE IN SYSTEMIC SCLEROSIS, 100
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 100
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 99
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 99
Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM 99
Liver cirrhosis in type II diabetic patients does not worsen insulin resistance 99
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 99
Opioid peptides and obesity 98
Cluster analysis identifies patients at risk of catheter-associated urinary tract infections in intensive care units: findings from the SPIN-UTI Network 98
Increased VEGF Expression but Impaired VEGF Receptor Signaling In The Myocardium of Diabetic Type 2 Patients with Chronic Coronary Heart Disease 97
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial 97
Totale 13.143
Categoria #
all - tutte 58.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022878 73 5 10 34 301 13 10 22 25 55 104 226
2022/20231.770 150 63 30 156 160 140 5 102 849 26 35 54
2023/2024664 54 33 29 57 230 77 7 16 5 8 58 90
2024/20252.099 6 36 16 40 342 241 329 171 314 224 215 165
2025/20268.999 364 360 433 396 774 5.100 489 321 313 211 162 76
Totale 16.871